Corona Remedies Limited IPO
Corona Remedies Limited IPO
Corona Remedies Limited IPO
₹ 14868 / 14 Shares Shares
Minimum Investment
Corona Remedies Limited IPO
Issues Price
₹1008-1062 per equity share
Corona Remedies Limited IPO
Open Date
08 Dec 2025
Close Date
10 Dec 2025
Lot Size
14
Min. Investment
₹ 14868
Issue Price
₹1008-1062
Listing Date
15 Dec 2025
Issues Size
61,71,101 shares(aggregating up to ₹655.37 crore)
Face Value
₹10 Per Equity Share
Total Shares Offered
14 Shares
Offered To Public
14 Shares
Corona Remedies Limited IPO
Incorporated in August 2004, Corona Remedies Limited is a pharmaceutical company developing, manufacturing, and marketing products in women's healthcare, cardiology, pain management, urology, and other therapeutic areas. The diversified portfolio of the company as of December 2024 comprises 67 brands across therapeutic areas such as women's healthcare, cardio-diabeto, pain management, urology, and multispecialty pharmaceuticals, including vitamins/minerals/nutrition, gastrointestinal, and respiratory.The company has a pan-India marketing and distribution network with 2,598 medical representatives in 22 states, enabling effective engagement with healthcare professionals and hospitals, thus consolidating its presence in the IPM and ensuring deep penetration in therapeutic areas. Presently, the company owns two manufacturing facilities located in the states of Gujarat. As of December 31, 2024, the company had 88 R&D employees.
Founded In
2004
Managing Director
Dr. Kirtikumar Laxmidas Mehta
Parent Organization
Corona Remedies Limited IPO
Application Details of Corona Remedies Limited IPO.
| Apply as | Price Range | Apply Upto |
|---|---|---|
| Retail (min) | ₹1008-1062 | ₹14,868 |
| Retail(max) | ₹1008-1062 | ₹1,93,284 |
| SHNI(min) | ₹1008-1062 | ₹2,08,152 |
| SHNI(max) | ₹1008-1062 | ₹9,96,156 |
| BHNI(min) | ₹1008-1062 | ₹10,11,024 |
For Corona Remedies Limited IPO, eligible investors can apply as Regular.
Open On12 Dec 2025
Close On16 Dec 2025
Price Range₹2061-2165
Testimonial
Genuine Review Form Statisifed Customers
KSquare’s team explained everything clearly. I never thought borrowing against my mutual funds would be this easy.
KSquare makes it simple to understand which NFO suits you. Their comparisons and insights saved me hours of research. Totally recommend it!
KSquare’s New Fund Offering updates are timely and insightful. I’ve participated in two NFOs already, and the results have been quite impressive and transparent.
Thanks to KSquare’s New Fund Offering alerts, I’ve been able to catch early opportunities that matched my long-term strategy and risk appetite.
KSquare helped me plan my retirement with complete clarity. The SIP guidance was simple, personalised, and stress-free. I now feel financially confident about my future and family responsibilities.
I always tell clients about KSquare now. Their SIP system is efficient and perfectly tailored to long-term growth strategies. It’s my go-to investment tool.
Managing money in India while living overseas used to be stressful. KSquare’s platform made everything manageable and safe.
It’s rare to find an investing service that explains NFOs in such a relatable way. KSquare really bridges that gap. Very impressed!
The automatic deductions and growth charts at KSquare keep me informed and on track. It’s great for anyone serious about long-term financial goals.
KSquare’s approach to New Fund Offerings really impressed me. I finally feel confident participating in something I once thought was too complicated.
FAQ's
Frequenlty Asked Question
How do I track the performance of an NFO after investment?
Once listed, KSquare provides regular updates and performance tracking via your investor dashboard.
What happens if I stop my SIP before maturity?
You can withdraw your invested amount anytime. However, early exits might impact your long-term growth potential.
What is the minimum amount required to start a SIP?
You can begin a SIP with as little as ₹500 per month, making it accessible for investors of all income levels.
Which types of mutual funds are eligible for loans?
Typically, equity and debt mutual fund units held in demat form are eligible. KSquare helps confirm your fund’s eligibility instantly.
Is NPS a market-linked investment?
Yes, NPS invests in equity and debt instruments, so returns vary with market performance over time.
Can I change my fund manager in NPS via KSquare?
Yes, KSquare allows you to switch your fund manager or investment option once a year through your dashboard.
Can I pause or stop my SIP anytime with KSquare?
Yes, KSquare allows you to pause, stop, or modify your SIP plan anytime through your account dashboard.
Can I nominate someone for my NPS account?
Yes, nomination is mandatory and can be easily added or updated through your KSquare profile.
Ksquare Timeline Pvt. Ltd. is an AMFI Registered Mutual Fund Distributor having ARN No. 146262. Mutual Fund investments are subject to market risks. Please read all scheme related documents carefully before investing. This website is intended only for informational and self-help purposes and should not be considered as investment advice or return guarantee. Past performance is not indicative of future results. Terms & Conditions apply.